Study of Nimotuzumab, Radiation Therapy and Cisplatin Versus Radiation Therapy and Cisplatin for Treatment of Stage IB e IVA UCC(CORUS)

NCT01301612 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Regulatory requirement. A phase III study is being designed.

Conditions

Carcinoma
Adenocarcinoma
Uterine Cervix Adenosquamous Carcinoma

Interventions

DRUG: Nimotuzumab
DRUG: Cisplatin
RADIATION: Brachytherapy
DRUG: Cisplatin
RADIATION: Radiation Therapy

Sponsor

Eurofarma Laboratorios S.A.